Article
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
11 Apr 2024
Abstract excerpt
The treatment of acute myeloid leukemia (AML) with adverse genetics remains unsatisfactory, with very low response rates to standard chemotherapy and shorter durations of remission commonly observed in these patients. The complex biology of AML with adverse genetics is continuously evolving. Herein, we discuss recent advances in the field focusing on the contribution of molecular drivers of leukemia biogenesis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
